Print

IHV01

NCT02756208

Trial Details:

I Ongoing
Profectus Biosciences, Institute of Human Virology (IHV), University of Maryland School of Medicine
Full-Length Single Chain (FLSC)
Healthy adults
RandD/trials/Lists/ClinicalTrialsList
7/1/2018
Env gp120 clade B fused to the N terminus of the two outer domains of CD4 by a flexible polypeptide linker.
0.25 mL FLSC Vaccine Group Fifteen volunteers will be vaccinated with 75 mcg (0.25 mL) FLSC on study days 0, 28, 56 and 168.  OR 0.5 mL FLSC Vaccine Group Fifteen volunteers will be vaccinated with 150 mcg (0.5 mL) FLSC on study days 0, 28, 56 and 168. OR